COVID-19 Vaccine Project under the COVID-19 Crisis Recovery Facility

Start & End Date: 2022-2023

Country/Countries: Turkey

Multilateral Institution(s) Involved: Asian Infrastructure Investment Bank, World Bank

Turkey was hit severly by the covid-19 pandemic. The project wants to strengthen Turkey’s capacity to avert the potentially high health and human cost of the COVID-19 pandemic by reinforcing mitigation and disease management.

The objective is to enable affordable and equitable access to COVID-19 vaccines in Turkey and to help ensure effective vaccine deployment by strengthening the vaccination system. The proposed loan will be financed under the AIIB’s COVID-19 Crisis Recovery Facility in the amount of EUR221.2 million. AIIB will co-finance the World Bank (WB)’s Additional Financingof the Turkey Emergency COVID-19 Health Project. The Project comprises the vaccine procurement (EUR 662.45 million) and vaccine awareness and communication activities (EUR 1.25 million). AIIB will finance the same activities as the WB on a pro rata basis. The implementation period is expected from July 2022 to December 2023.

"The proposed Project results will include: (a) About 62.5 million doses of COVID-19 vaccines deployed; (b) Vaccination coverage of about 37.2% of total population against COVID-19; and (c) The recommendation on vaccination for pregnant women will be included in the COVID-19 vaccine administration strategies"